about
Older men who use computers have lower risk of dementiaAir pollution, oxidative stress, and Alzheimer's diseaseReceptor for advanced glycation end products and its involvement in inflammatory diseasesEconomic considerations in the management of Alzheimer's diseasePrevention of Alzheimer's diseaseInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care settingMini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community settingInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) settingInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populationsIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a general practice (primary care) settingIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care settingIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community settingMini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community settingAspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseaseEnteral tube feeding for older people with advanced dementiaGpr3 stimulates Aβ production via interactions with APP and β-arrestin2Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersThe Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motifFunctional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesisSelective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's diseaseLong-term course and effectiveness of combination therapy in Alzheimer diseaseThe clinical course of advanced dementiaAlzheimer's disease; taking the edge off with cannabinoids?A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease.Linking lipids, Alzheimer's and LXRs?THE ROLE OF CYSTEINE PROTEASE IN ALZHEIMER DISEASENeurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's diseaseOverview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal CompoundsObesity, the deadly quartet and the contribution of the neglected daily organ rest - a new dimension of un-health and its preventionRole of apolipoprotein E in neurodegenerative diseasesThe Epidemiological Scale of Alzheimer's DiseaseClearance systems in the brain-implications for Alzheimer diseaseIdentifying the components of clinical vignettes describing Alzheimer's disease or other dementias: a scoping reviewTDP-43: a new player on the AD field?Type 2 diabetes and cognitive impairment: contributions from neuroimagingRole of environmental contaminants in the etiology of Alzheimer's disease: a reviewThe clinical problem of symptomatic Alzheimer disease and mild cognitive impairmentCommon defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploringMeta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic CriteriaAlzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions
P2860
Q21134062-C3281D87-EF5C-4479-9D03-48D1BBD7950FQ21285060-D4495E68-568B-4F0A-AAC2-40CD5B4B0D43Q21285070-C2F27FA6-C9C2-4754-A09D-9C8C4F7EDF25Q22241448-BC01EF03-10F5-4FFB-8058-F2ACE15D7E84Q22248031-CE723693-CB14-4F0A-83B8-6970F981C02FQ24187059-03349143-55E9-40CF-B6F3-AA4193B63AB3Q24187908-26C95D2A-AA2C-413D-89E4-D285979FF2B9Q24194747-D46971F1-A1A9-4256-B213-719362F4A843Q24194962-3A817961-CE2A-40FB-A4E3-C06869C8758FQ24197665-9EF9037C-61CF-45C0-883B-02789E7348F0Q24197672-60D45434-70EF-4DB4-9541-4FC6C9239A81Q24200918-B5A1111C-CBAA-468A-BD22-EBC153D264B7Q24202610-213DEF83-9F23-4258-8A44-F8956C89E7A4Q24203739-E8F02070-E396-482F-B9D4-FCA65B6B75C7Q24241361-D34F3C02-638C-468E-B493-FA8ED3CD2B77Q24337284-29C73449-CBB7-4309-BB9A-A522294F0A6DQ24562763-01644487-DF87-40F8-908B-F31AC7A5C1BFQ24600203-94EB6D96-DA1B-4A70-8829-742154C164C7Q24606614-BB6381E3-210E-47CB-8CA5-AEE97E6B8AC7Q24633911-BC64071D-ACBF-4256-B959-43915A5E4923Q24642161-98D3ABDF-9974-4C98-A71E-6E857EEB7786Q24655041-C21DAE92-FBEA-4889-9105-9B69AB32CB69Q24681412-FFF361B1-67BF-4532-BFA3-1C94F05E29D7Q24816672-E9607550-C6AA-45FD-815E-34BE822F3201Q25255165-2E9DE3D7-A87A-4AE1-B2D6-EC3AC5D3AA40Q26740104-E5B426C1-D84B-482D-87B7-0851D0EEC7DAQ26741247-63361EC4-15B0-4EE2-B667-42EBB46A8FBCQ26749061-C46F0BE1-8687-4EB0-93B5-5B2248A21F4FQ26796607-0DDCB56E-5FEC-4AC5-8A28-0F01D095DBC6Q26799413-53DD3DD8-B2F8-4501-88EB-D46A2C6C12FCQ26801246-B3235CB1-2FDE-4E34-935B-B2B9869CB40EQ26801541-2717BF0D-D09E-4DB5-A0D4-0FE8DABF68BDQ26801830-7D98126B-C6EC-4F47-8357-782B9890468CQ26823723-08729440-AF70-4683-AB82-625F7A72EB80Q26825253-6FBF9E36-3F52-4302-A446-69645D0BB2D4Q26830320-CB0A794C-F370-4638-A66D-DEA391FA8180Q26849795-AE2F6FF9-AF53-4F7D-B21A-FBD1C2EBFE06Q26861082-BF9E6887-F6E1-4CB9-AC00-69E0195B003CQ26864063-1D974702-52B6-4883-9CC8-7F62B32F4AB7Q26864965-28C995F0-2F31-4290-B2C6-847F91A5689E
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Alzheimer Disease in the US Population
@ast
Alzheimer Disease in the US Population
@en
Alzheimer Disease in the US Population
@en-gb
Alzheimer Disease in the US Population
@nl
type
label
Alzheimer Disease in the US Population
@ast
Alzheimer Disease in the US Population
@en
Alzheimer Disease in the US Population
@en-gb
Alzheimer Disease in the US Population
@nl
altLabel
Alzheimer disease in the US population: prevalence estimates using the 2000 census
@en
prefLabel
Alzheimer Disease in the US Population
@ast
Alzheimer Disease in the US Population
@en
Alzheimer Disease in the US Population
@en-gb
Alzheimer Disease in the US Population
@nl
P2093
P3181
P1433
P1476
Alzheimer Disease in the US Population
@en
P2093
David A. Bennett
Denis A. Evans
Julia L. Bienias
Liesi E. Hebert
Paul A. Scherr
P3181
P356
10.1001/ARCHNEUR.60.8.1119
P407
P577
2003-08-01T00:00:00Z